Molecular Vision announces new non-executive chairman
This article was originally published in Clinica
Executive Summary
Molecular Vision (London, UK) has appointed Peter Woodford as non-executive chairman; he replaces Dr Chris Wright, who will continue to serve on the board as a non-executive director. Mr Woodford has over 35 years’ experience and joins from Roche Diagnostics, where he was responsible for the global strategic and commercial activities of the firm’s diabetes care division. His appointment is expected to strengthen the company as it prepares to commercialise its low-cost point-of-care diagnostic test technology.